Immune checkpoint inhibitors: therapeutic advances in melanoma

by Márquez-Rodas, Ivan, Cerezuela, Pablo, Soria, Ainara, Berrocal, Alfonso, Riso, Aldo, González-Cao, María, Martín-Algarra, Salvador
Published in Ann Transl Med (2015)

Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)

by Espinosa, Enrique, Márquez-Rodas, Ivan, Soria, Ainara, Berrocal, Alfonso, Manzano, Jose Luis, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Published in Ann Transl Med (2017)

Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM)

by Soria, Ainara, Manzano, Jose Luis, Berrocal, Alfonso, Espinosa, Enrique, Marquez-Rodas, Ivan, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Published in Ann Transl Med (2017)

Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene

by Tanic, Miljana, Yanowsky, Kira, Rodriguez-Antona, Cristina, Andrés, Raquel, Márquez-Rodas, Iván, Osorio, Ana, Benitez, Javier, Martinez-Delgado, Beatriz
Published 2012

Simultaneous diagnosis of liver PEComa in a family with known Li–Fraumeni syndrome: a case report

by Galera López, María del Mar, Márquez Rodas, Iván, Agra Pujol, Carolina, García Pérez, Ángela, Velasco Sánchez, Enrique, Álvarez Álvarez, Rosa
Published in Clin Sarcoma Res (2020)

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

by Garcia‐Carbonero, Rocio, Marquez‐Rodas, Ivan, de la Cruz‐Merino, Luis, Martinez‐Trufero, Javier, Cabrera, Miguel Angel, Piulats, Jose Maria, Capdevila, Jaume, Grande, Enrique, Martin‐Algarra, Salvador, Berrocal, Alfonso
Published in Oncologist (2019)

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

by Ascierto, Paolo A., Bastholt, Lars, Ferrucci, Pier F., Hansson, Johan, Márquez Rodas, Iván, Payne, Miranda, Robert, Caroline, Thomas, Luc, Utikal, Jochen S., Wolter, Pascal, Kudlac, Amber, Tuson, Harriet, McKendrick, Jan
Published in Melanoma Res (2018)

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

by Long, Georgina V., Weber, Jeffrey S., Larkin, James, Atkinson, Victoria, Grob, Jean-Jacques, Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Márquez-Rodas, Ivan, McNeil, Catriona, Schmidt, Henrik, Briscoe, Karen, Baurain, Jean-François, Hodi, F. Stephen, Wolchok, Jedd D.
Published in JAMA Oncol (2017)

Melanoma proteomics suggests functional differences related to mutational status

by Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Díaz-Almirón, Mariana, Fortes, Claudia, Ferrer-Gómez, María, López-Vacas, Rocío, Parra Blanco, Verónica, Márquez-Rodas, Iván, Soria, Ainara, Fresno Vara, Juan Ángel, Espinosa, Enrique
Published in Sci Rep (2019)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

by Aznar, M. Angela, Planelles, Lourdes, Perez-Olivares, Mercedes, Molina, Carmen, Garasa, Saray, Etxeberría, Iñaki, Perez, Guiomar, Rodriguez, Inmaculada, Bolaños, Elixabet, Lopez-Casas, Pedro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Marquez-Rodas, Ivan, Teijeira, Alvaro, Quintero, Marisol, Melero, Ignacio
Published in J Immunother Cancer (2019)

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

by Lebbé, Celeste, Meyer, Nicolas, Mortier, Laurent, Marquez-Rodas, Ivan, Robert, Caroline, Rutkowski, Piotr, Menzies, Alexander M., Eigentler, Thomas, Ascierto, Paolo A., Smylie, Michael, Schadendorf, Dirk, Ajaz, Mazhar, Svane, Inge Marie, Gonzalez, Rene, Rollin, Linda, Lord-Bessen, Jennifer, Saci, Abdel, Grigoryeva, Elena, Pigozzo, Jacopo
Published in J Clin Oncol (2019)

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

by Martín, Miguel, Custodio, Sara, de las Casas, Maria-Luisa Maestro, García-Sáenz, José-Ángel, de la Torre, Julio-César, Bellón-Cano, Jose-María, López-Tarruella, Sara, Vidaurreta-Lazaro, Marta, de la Orden, Virginia, Jerez, Yolanda, Márquez-Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz-Rubio, Eduardo
Published 2013

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

by Gonzalez-Cao, Maria, Puertolas, Teresa, Riveiro, Mar, Muñoz-Couselo, Eva, Ortiz, Carolina, Paredes, Roger, Podzamczer, Daniel, Manzano, Jose Luis, Molto, Jose, Revollo, Boris, Carrera, Cristina, Mateu, Lourdes, Fancelli, Sara, Espinosa, Enrique, Clotet, Bonaventura, Martinez-Picado, Javier, Cerezuela, Pablo, Soria, Ainara, Marquez-Rodas, Ivan, Mandala, Mario, Berrocal, Alfonso
Published in J Immunother Cancer (2021)

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

by Karachaliou, Niki, Gonzalez-Cao, Maria, Crespo, Guillermo, Drozdowskyj, Ana, Aldeguer, Erika, Gimenez-Capitan, Ana, Teixido, Cristina, Molina-Vila, Miguel Angel, Viteri, Santiago, De Los Llanos Gil, Maria, Algarra, Salvador Martin, Perez-Ruiz, Elisabeth, Marquez-Rodas, Ivan, Rodriguez-Abreu, Delvys, Blanco, Remedios, Puertolas, Teresa, Royo, Maria Angeles, Rosell, Rafael
Published in Ther Adv Med Oncol (2018)

Dabrafenib plus trametinib in patients with BRAF V600–mutant melanoma brain metastases (COMBI-MB): a multi-cohort, open-label, phase 2 trial

by Davies, Michael A, Saiag, Philippe, Robert, Caroline, Grob, Jean-Jacques, Flaherty, Keith T, Arance, Ana, Chiarion-Sileni, Vanna, Thomas, Luc, Lesimple, Thierry, Mortier, Prof Laurent, Moschos, Stergios J, Hogg, David, Márquez-Rodas, Iván, Del Vecchio, Michele, Lebbé, Céleste, Meyer, Nicolas, Zhang, Ying, Huang, Yingjie, Mookerjee, Bijoyesh, Long, Georgina V
Published in Lancet Oncol (2017)

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

by D’Angelo, Sandra P., Larkin, James, Sosman, Jeffrey A., Lebbé, Celeste, Brady, Benjamin, Neyns, Bart, Schmidt, Henrik, Hassel, Jessica C., Hodi, F. Stephen, Lorigan, Paul, Savage, Kerry J., Miller, Wilson H., Mohr, Peter, Marquez-Rodas, Ivan, Charles, Julie, Kaatz, Martin, Sznol, Mario, Weber, Jeffrey S., Shoushtari, Alexander N., Ruisi, Mary, Jiang, Joel, Wolchok, Jedd D.
Published in J Clin Oncol (2017)

Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification

by Echavarria, Isabel, López-Tarruella, Sara, Picornell, Antoni, García-Saenz, Jose Ángel, Yolanda Jerez, Y, Hoadley, Katherine, Gómez, Henry L, Moreno, Fernando, Del Monte-Millan, María, Márquez-Rodas, Iván, Alvarez, Enrique, Ramos-Medina, Rocío, Gayarre, Javier, Massarrah, Tatiana, Ocaña, Inmaculada, Cebollero, María, Fuentes, Hugo, Barnadas, Agusti, Ballesteros, Ana Isabel, Bohn, Uriel, Perou, Charles M, Martin, Miguel
Published in Clin Cancer Res (2018)

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

by Márquez-Rodas, Iván, Pollán, Marina, Escudero, María José, Ruiz, Amparo, Martín, Miguel, Santaballa, Ana, Martínez del Prado, Purificación, Batista, Norberto, Andrés, Raquel, Antón, Antonio, Llombart, Antonio, Fernandez Aramburu, Antonio, Adrover, Encarnación, González, Sonia, Seguí, Miguel Angel, Calvo, Lourdes, Lizón, José, Rodríguez Lescure, Álvaro, Ramón y Cajal, Teresa, Llort, Gemma, Jara, Carlos, Carrasco, Eva, López-Tarruella, Sara
Published in PLoS One (2017)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

by Martin, Miguel, Ramos-Medina, Rocio, Bernat, Rebeca, García-Saenz, Jose Angel, del Monte-Millan, Maria, Alvarez, Enrique, Cebollero, Maria, Moreno, Fernando, Gonzalez-Haba, Eva, Bueno, Oscar, Romero, Paula, Massarrah, Tatiana, Echavarria, Isabel, Jerez, Yolanda, Herrero, Blanca, Gonzalez del Val, Ricardo, Lobato, Nerea, Rincon, Patricia, Palomero, Maria Isabel, Marquez-Rodas, Ivan, Lizarraga, Santiago, Asensio, Fernando, Lopez-Tarruella, Sara
Published in Sci Rep (2021)

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

by Espinosa, Enrique, Soriano, Virtudes, Malvehy, Josep, Berrocal, Alfonso, Martínez de Prado, Purificación, Quindós, María, Soria, Ainara, Márquez-Rodas, Iván, Palacio, Isabel, Cerezuela, Pablo, López-Vivanco, Guillermo, Alonso, Lorenzo, Samaniego, Elia, Ballesteros, Ana, Puértolas, Teresa, Díaz-Beveridge, Rodrigo, de la Cruz-Merino, Luis, López Castro, Rafael, López López, Rafael, Stevinson, Kendall, del Barrio, Patricia, Tornamira, Maria V., Guillém, Vicente, Martín-Algarra, Salvador
Published in Melanoma Res (2016)